statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

NEW YORK, April 04, 2024 (GLOBE NEWSWIRE) -- Wolf Popper LLP is investigating potential claims on behalf of investors in the following Special Purpose Acquisition Companies (SPAC). The stock prices...

Wolf Popper LLP Announces Investigations on Behalf of Investors in Materially Underperforming Special Purpose Acquisition Companies

InvestorPlace - Stock Market News, Stock Advice & Trading Tips
SNTI stock results show that Senti Biosciences missed analyst estimates for earnings per share the fourth quarter of 2023.
The post SNTI...

SNTI Stock Earnings: Senti Biosciences Misses EPS for Q4 2023

IND for SENTI-202, a potential first-in-class logic-gated treatment for AML, cleared by the U.S. FDA; First patient dosing anticipated in the second quarter of 2024 Cash and anticipated...

Senti Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Reviews Recent Highlights

Senti Biosciences, Inc. (NASDAQ:SNTI  Get Free Report) saw a large drop in short interest in the month of February. As of February 29th, there was short interest totalling 269,900 shares, a...

Short Interest in Senti Biosciences, Inc. (NASDAQ:SNTI) Decreases By 21.9%

Senti Biosciences (NASDAQ:SNTI  Get Free Report) and ZIVO Bioscience (NASDAQ:ZIVO  Get Free Report) are both small-cap medical companies, but which is the better investment? We will...

Head to Head Review: Senti Biosciences (NASDAQ:SNTI) versus ZIVO Bioscience (NASDAQ:ZIVO)

Senti Biosciences (NASDAQ:SNTI  Get Free Report) and X4 Pharmaceuticals (NASDAQ:XFOR  Get Free Report) are both small-cap medical companies, but which is the better business? We will...

Senti Biosciences (NASDAQ:SNTI) & X4 Pharmaceuticals (NASDAQ:XFOR) Head to Head Analysis

Senti Biosciences to reduce workforce by 37...

Senti Biosciences to reduce workforce by 37%

Strategic resource allocation to focus investment on clinical development of SENTI-202 and SENTI-301A partnership in China; interim data from Phase 1 clinical trial of SENTI-202 expected in 2H 2024...

Senti Bio Announces Strategic Steps to Prioritize Investment in Lead Clinical Program

Senti Biosciences, Inc. is a biotechnology company. It engages in the business of developing next-generation cell and gene therapies engineered with a gene circuit platform technology to fight challenging diseases. The company was founded by Timothy K. Lu, Wilson Wong, and Philip Lee on June 9, 2016 and is headquartered in South San Francisco, CA.

Volume	31,770.00
52-Wk High	$1.10
52-Wk Low	$0.2701

SNTI Senti Biosciences Inc.

About

Feed

News

Sentiment

Fundamentals